The aim of the study is to present the personal improvement of tubal reanastomosis technique over the years for the women who, for several reasons, change their mind and are willing to get pregnant following the administration of tubal ligation. 21 women on whom tubal reanastomosis had previously been administered after having been deemed eligible for surgery and who changed their mind and applied to the clinic I work for to get pregnant again were included in the study. The postoperative pregnancy rates and pregnancy results pertaining to 14 of these women were analyzed. The rate of pregnancy following tubal reanastomosis is 72%, and 46% of those who got pregnant achieved term. Tubal recanalization is a method in which complications such as multiple pregnancy and ovarian hyperstimulation syndrome (OHSS) do not develop in addition to having a higher patient compatibility and success rate when compared to IVF (In Vitro Fertilization). Besides these benefits, tubal recanalization offers the opportunity of concurrent intervention if pathologies such as endometrial polyps, ovary cyst, myoma and adhesion exist in the patient. Tubal renastomosis is an alternative treatment to IVF in the selected patient group by taking into consideration various factors including the age of the women, the length of the tube following ligation, hormonal panel and the spermiogram of the spouse.
Sivans and at University of Health Sciences Kanuni Training and Research Hospital, Gynecology and Obstetrics Clinic in Trabzon were retrospectively scanned. The application for the approval of ethics committee was done for the research
Sivans and at University of Health Sciences Kanuni Training and Research Hospital, Gynecology and Obstetrics Clinic
Primary Language | English |
---|---|
Subjects | Obstetrics and Gynaecology |
Journal Section | Case Report |
Authors | |
Publication Date | December 31, 2024 |
Submission Date | December 17, 2024 |
Acceptance Date | December 23, 2024 |
Published in Issue | Year 2024 Volume: 41 Issue: 4 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.